C12Y 301/11002
Exodeoxyribonuclease iii
Official title: Exodeoxyribonuclease III (3.1.11.2)
C12Y301/11002 (Exodeoxyribonuclease iii) appears on 21 US grants and 36 published applications in this corpus.
Search patents in C12Y- Granted patents
- 21
- Published applications
- 36
- Assignees
- 19
- Inventors
- 71
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 4 | 3 |
| 2003 | 1 | 4 |
| 2004 | 5 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 3 |
| 2017 | 0 | 0 |
| 2018 | 1 | 2 |
| 2019 | 1 | 4 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 3 | 2 |
| 2023 | 1 | 3 |
| 2024 | 0 | 2 |
| 2025 | 2 | 5 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations20 Jan 2026US 12,529,100 B2Roche Sequencing Solutions, Inc.
- DNA compositions and related methods20 May 2025US 12,303,526 B2Flagship Pioneering Innovations Vii, LLC
- Methods for seamless nucleic acid assembly8 Apr 2025US 12,270,028 B2Twist Bioscience Corporation
- Use of exonucleases to improve CRISPR/CAS-mediated genome editing6 Jun 2023US 11,667,911 B2Editas Medicine, Inc.
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations6 Dec 2022US 11,519,026 B2Roche Sequencing Solutions, Inc.
- Strand Displacement-Based Gene Editing Method and System and Use Thereof17 Sep 2026US 2026/0275310 A1
- Dna compositions and related methods11 Jun 2026US 2026/0158053 A1Flagship Pioneering Innovations Vii, LLC
- Method for preparing linear closed dna and plasmid for use in the method26 Feb 2026US 2026/0055392 A1Zhenjiang Probio Biotech Co., Ltd.
- Cas exonuclease fusion proteins and associated methods for excision, inversion, and site specific integration18 Dec 2025US 2025/0382598 A1Syngenta Crop Protection AG
- A DNA Assembly Mix And Method Of Uses Thereof16 Oct 2025US 2025/0320476 A1National University of Singapore
Most cited
By later US patents
- Saturation mutagenesis in directed evolution147US 6,171,820 B2Diversa Corporation · 2001
- Non-stochastic generation of genetic vaccines108US 6,479,258 B1Diversa Corporation · 2002
- Exonuclease-mediated nucleic acid reassembly in directed evolution93US 6,361,974 B1Diversa Corporation · 2002
- Non-stochastic generation of genetic vaccines and enzymes77US 6,713,279 B1Diversa Corporation · 2004
- End selection in directed evolution72US 6,773,900 B2Diversa Corporation · 2004